Towards 2000—New pathways for the clinical management of acute ischemic syndromes: Introductory editorial to symposium Paul Wayne Armstrong EditorialNotes Pages: 99 - 100
Acute myocardial infarction in Canada: New epidemiologic insights on incidence, therapy, and risk Terrence MontaguePatricia MontagueThe Clinical Quality Improvement Network (CQIN) Investigators OriginalPaper Pages: 101 - 105
Identifying patient risk: The basis for rational discharge planning after acute myocardial infarction L. Kristin NewbyRobert M. Califf OriginalPaper Pages: 107 - 115
Time to reperfusion: The critical modulator in thrombolysis and primary angioplasty Christopher P. CannonEugene Braunwald OriginalPaper Pages: 117 - 125
New therapeutic opportunities for heparins: What does low molecular weight heparin offer? A. G. G. Turpie OriginalPaper Pages: 145 - 149
Economics and quality of life after acute myocardial infarction: Insights from GUSTO-I Daniel B. Mark OriginalPaper Pages: 151 - 155
Costs in perspective: Understanding cost-effectiveness analysis Allan S. Detsky OriginalPaper Pages: 157 - 161